These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10858337)

  • 21. Formyl peptide receptor-mediated proinflammatory consequences of peptide deformylase inhibition in Staphylococcus aureus.
    Mader D; Rabiet MJ; Boulay F; Peschel A
    Microbes Infect; 2010 May; 12(5):415-9. PubMed ID: 20156579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of type II peptide deformylase from Staphylococcus aureus.
    Baldwin ET; Harris MS; Yem AW; Wolfe CL; Vosters AF; Curry KA; Murray RW; Bock JH; Marshall VP; Cialdella JI; Merchant MH; Choi G; Deibel MR
    J Biol Chem; 2002 Aug; 277(34):31163-71. PubMed ID: 12048187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide deformylase as an antibacterial drug target: target validation and resistance development.
    Apfel CM; Locher H; Evers S; Takács B; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1058-64. PubMed ID: 11257016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis for the design of antibiotics targeting peptide deformylase.
    Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
    Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antibacterial activity of peptide deformylase inhibitors.
    Huntington KM; Yi T; Wei Y; Pei D
    Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression, purification, and activity assay of peptide deformylase from Escherichia coli and Staphylococcus aureus.
    Che X; Hu J; Wang L; Zhu Z; Xu Q; Lv J; Fu Z; Sun Y; Sun J; Lin G; Lu R; Yao Z
    Mol Cell Biochem; 2011 Nov; 357(1-2):47-54. PubMed ID: 21603885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-Amino-4-deoxy-L-arabinose. Identification and function oF UDP-4-deoxy-4-formamido-L-arabinose.
    Breazeale SD; Ribeiro AA; McClerren AL; Raetz CR
    J Biol Chem; 2005 Apr; 280(14):14154-67. PubMed ID: 15695810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eukaryotic peptide deformylases. Nuclear-encoded and chloroplast-targeted enzymes in Arabidopsis.
    Dirk LM; Williams MA; Houtz RL
    Plant Physiol; 2001 Sep; 127(1):97-107. PubMed ID: 11553738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure analysis of peptide deformylases from Streptococcus pneumoniae, Staphylococcus aureus, Thermotoga maritima and Pseudomonas aeruginosa: snapshots of the oxygen sensitivity of peptide deformylase.
    Kreusch A; Spraggon G; Lee CC; Klock H; McMullan D; Ng K; Shin T; Vincent J; Warner I; Ericson C; Lesley SA
    J Mol Biol; 2003 Jul; 330(2):309-21. PubMed ID: 12823970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
    Pratt LM; Beckett RP; Davies SJ; Launchbury SB; Miller A; Spavold ZM; Todd RS; Whittaker M
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2585-8. PubMed ID: 11551755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes.
    Nilsson AI; Zorzet A; Kanth A; Dahlström S; Berg OG; Andersson DI
    Proc Natl Acad Sci U S A; 2006 May; 103(18):6976-81. PubMed ID: 16636273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.
    Fu H; Dahlgren C; Bylund J
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2545-50. PubMed ID: 12878517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-crystallization of Staphylococcus aureus peptide deformylase (PDF) with potent inhibitors.
    Harris MS; Bock JH; Choi G; Cialdella JS; Curry KA; Deibel MR; Jacobsen EJ; Marshall VP; Murray RW; Vosters AF; Wolfe CL; Yem AW; Baldwin ET
    Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2153-6. PubMed ID: 12454484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil chemotaxis by pathogen-associated molecular patterns--formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus.
    Dürr MC; Kristian SA; Otto M; Matteoli G; Margolis PS; Trias J; van Kessel KP; van Strijp JA; Bohn E; Landmann R; Peschel A
    Cell Microbiol; 2006 Feb; 8(2):207-17. PubMed ID: 16441432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peptide-deformylase inhibitors, a new class of antibiotics].
    Dubreuil L
    Presse Med; 2002 Nov; 31(38):1810-2. PubMed ID: 12497724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Putative Bacterial ABC Transporter Circumvents the Essentiality of Signal Peptidase.
    Morisaki JH; Smith PA; Date SV; Kajihara KK; Truong CL; Modrusan Z; Yan D; Kang J; Xu M; Shah IM; Mintzer R; Kofoed EM; Cheung TK; Arnott D; Koehler MF; Heise CE; Brown EJ; Tan MW; Hazenbos WL
    mBio; 2016 Sep; 7(5):. PubMed ID: 27601569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide Deformylase (def) is essential in Mycobacterium smegmatis, but the essentiality is compensated by inactivation of methionine formylation.
    Naor N; Gadot O; Meir M; Barkan D
    BMC Microbiol; 2019 Oct; 19(1):232. PubMed ID: 31655553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning and characterization of the fmt gene which affects the methicillin resistance level and autolysis in the presence of triton X-100 in methicillin-resistant Staphylococcus aureus.
    Komatsuzawa H; Sugai M; Ohta K; Fujiwara T; Nakashima S; Suzuki J; Lee CY; Suginaka H
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2355-61. PubMed ID: 9371333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy number.
    Dean CR; Narayan S; Richards J; Daigle DM; Esterow S; Leeds JA; Kamp H; Puyang X; Wiedmann B; Mueller D; Voshol H; van Oostrum J; Wall D; Koehn J; Dzink-Fox J; Ryder NS
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1004-10. PubMed ID: 17220413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.